Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Michael J. Keating, K. B. McCredie, Moshe Talpaz et al.|Journal of Clinical Oncology|1991Cited by 249
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.Michael J. Keating, Emil J. Freireich, Terry L. Smith et al.|PubMed|1988Cited by 218